SAMRAT PHARMACHEM
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Samrat Pharmachem along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.47₹ 7.15
As on Oct 31, 2025, 4:01 PM IST
Samrat Pharmachem Price Performance
Today's LowToday's High
₹280.00₹306.80
₹296.80
52 Weeks' Low52 Weeks' High
₹271.10₹511.00
₹296.80
Open Price
₹290.30
Prev. Close
₹289.65
Volume
2,007
Over the last 5 years, the share price of Samrat Pharmachem has gained 20.26% CAGR. Over the past year, the corresponding return has been -37.70%.
Samrat Pharmachem’s current P/E of 19.03x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Samrat Pharmachem Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Samrat Pharmachem | 0.54 | -6.5 | -12.37 | -17.28 | -38.15 | -31.64 | 20.26 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | 3.73 | -7.6 | -9.08 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 6.34 | 10.85 | 14.59 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | 0.03 | -1.58 | -3.69 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.8 | -0.38 | -3.39 | 9.01 | 10.66 | 29.1 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -1.68 | 1.37 | -4.72 | 10.6 | 4.3 |
| Mankind Pharma | -2.15 | -2.43 | -7.14 | -0.11 | -11.57 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 2.64 | 10 | -2.99 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 5.56 | -4.31 | -10.42 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | 5.46 | -6.06 | -18.73 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 12.48 | 8.53 | -5.2 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -13.89 | -5.7 | -1.05 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -8.54 | 37.43 | 11.8 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 12.55 | 53.86 | 91.09 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -2.86 | 16.74 | 17.02 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -10.55 | -8 | -3.86 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -3.73 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -12.53 | -7.87 | -21.04 | 11.98 | 2 |
| Gland Pharma | -0.6 | -2.66 | -2.59 | 37.25 | 17.21 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -8.44 | -4.54 | -19.88 | 23.86 | 18.63 |
Over the last one year, Samrat Pharmachem has declined 38.15% compared to peers like Sun Pharmaceutical Industries (-9.08%), Divi's Laboratories (14.59%), Cipla (-3.69%). From a 5 year perspective, Samrat Pharmachem has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Samrat Pharmachem Financials
Samrat Pharmachem Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 290.6 | 290.39 |
| 10 | 294.84 | 293.02 |
| 20 | 299.42 | 298.1 |
| 50 | 311.86 | 310.84 |
| 100 | 332.39 | 325.82 |
| 200 | 343.53 | 346.04 |
Samrat Pharmachem Share Holding Pattern
In the latest quarter, Samrat Pharmachem remained same as its previous close in promoter holding, while DII stake decreased to 0.00%, FII holding rose to 3.24%, and public shareholding unchanged at 47.67% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Samrat Pharmachem Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 10, 2025, 8:27 PM IST | Samrat Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 27, 2025, 7:11 PM IST | Samrat Pharma - Corporate Action-Board approves Dividend |
| Sep 27, 2025, 6:48 PM IST | Samrat Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 26, 2025, 9:10 PM IST | Samrat Pharma - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 30, 2025 |
| Sep 25, 2025, 9:09 PM IST | Samrat Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM |
About Samrat Pharmachem
Samrat Pharmachem Ltd. is a Public Limited Listed company incorporated on 16/06/1992 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1992PLC017820 and registration number is 017820. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 285.86 Cr. and Equity Capital is Rs. 3.09 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No A2/3445, Ankleshwar Gujarat 393002
- Contact
Management
- Mr. Lalit MehtaChairman & Managing Director
- Mr. Rajesh MehtaExecutive Director & CFO
- Mr. Megh MehtaExecutive Director
- Ms. Renu DharodInd. Non-Executive Director
- Mr. Manishkumar PipaliaInd. Non-Executive Director
- Mr. Sachin KotharyInd. Non-Executive Director
- Ms. Megha JainInd. Non-Executive Director
FAQs on Samrat Pharmachem Share Price
What is the share price of Samrat Pharmachem?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Samrat Pharmachem is ₹296.80 as on Oct 31, 2025.
What kind of stock is Samrat Pharmachem?
The Samrat Pharmachem is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Samrat Pharmachem?
The market cap of Samrat Pharmachem is ₹91.70 Cr as on Oct 31, 2025.
What are today's High and Low prices of Samrat Pharmachem?
Today’s highest and lowest price of Samrat Pharmachem are ₹306.80 and ₹280.00.
What are the 52 Week High and 52 Week Low of Samrat Pharmachem?
The 52-week high/low is the highest and lowest price at which Samrat Pharmachem stock has traded in the past 52-week or nearly a year. The 52-week high of Samrat Pharmachem is ₹511.00 and 52-week low of Samrat Pharmachem is ₹271.10 as on Oct 31, 2025.
How has the Samrat Pharmachem performed historically in terms of returns?
The Samrat Pharmachem has shown returns of 2.47% over the past day, -6.5% for the past month, -13.46% over 3 months, -37.7% over 1 year, -31.64% across 3 years, and 20.26% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Samrat Pharmachem?
P/E ratio of and PB ratio of Samrat Pharmachem are 19.03 and 1.28 on Oct 31, 2025. While the company gives a dividend yield of 0.34 per annum.
✕
Market Pulse